Abstract:Epigenetic modifications, such as histone post-translational modifications, DNA methylation, and alteration of gene expression by non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are heritable changes that are independent from the genomic DNA sequence. These regulate gene activities and, therefore, cellular functions. Epigenetic modifications act in concert with transcription factors and play critical roles in B cell development and differentiation, thereby modulating antibody responses to foreign- and self-antigens. Upon antigen encounter by mature B cells in the periphery, alterations of these lymphocytes epigenetic landscape are induced by the same stimuli that drive the antibody response. Such alterations instruct B cells to undergo immunoglobulin (Ig) class switch DNA recombination (CSR) and somatic hypermutation (SHM), as well as differentiation to memory B cells or long-lived plasma cells for the immune memory. Inducible histone modifications, together with DNA methylation and miRNAs modulate the transcriptome, particularly the expression of activation-induced cytidine deaminase, which is essential for CSR and SHM, and factors central to plasma cell differentiation, such as B lymphocyte-induced maturation protein-1. These inducible B cell-intrinsic epigenetic marks guide the maturation of antibody responses. Combinatorial histone modifications also function as histone codes to target CSR and, possibly, SHM machinery to the Ig loci by recruiting specific adaptors that can stabilize CSR/SHM factors. In addition, lncRNAs, such as recently reported lncRNA-CSR and an lncRNA generated through transcription of the S region that form G-quadruplex structures, are also important for CSR targeting. Epigenetic dysregulation in B cells, including the aberrant expression of non-coding RNAs and alterations of histone modifications and DNA methylation, can result in aberrant antibody responses to foreign antigens, such as those on microbial pathogens, and generation of pathogenic autoantibodies, IgE in allergic reactions, as well as B cell neoplasia. Epigenetic marks would be attractive targets for new therapeutics for autoimmune and allergic diseases, and B cell malignancies.

B Cell Responses: Cell Interaction Dynamics and Decisions

B-cell Receptor Repertoire Sequencing: Deeper Digging into the Mechanisms and Clinical Aspects of Immune-Mediated Diseases

Antibody repertoire and gene expression dynamics of diverse human B cell states during affinity maturation

From Antibody Repertoires to Cell-Cell Interactions to Molecular Networks: Bridging Scales in the Germinal Center

Both sides now: evolutionary traits of antigens and B cells in tolerance and activation

B cell academy of the gut: an update on gut associated germinal centre B cell dynamics

The Interplay Between Innate-Like B Cells and Other Cell Types in Autoimmunity

Assessing human B cell repertoire diversity and convergence

T Cell/B Cell Collaboration and Autoimmunity: An Intimate Relationship

Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage

Towards a unifying model for B-cell receptor triggering

Combination of High-Resolution Structures for the B Cell Receptor and Co-Receptors Provides an Understanding of Their Interactions with Therapeutic Antibodies

Long-term B cell memory emerges at uniform relative rates in the human immune response

Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response

From SAP‐less T Cells to Helpless B Cells and Back: Dynamic T–B Cell Interactions Underlie Germinal Center Development and Function

B Cell Activation and Autoantibody Production in Autoimmune Diseases.

B-cell biology and development

Advances and challenges in investigating B-cells via single-cell transcriptomics

Systems Analysis Reveals High Genetic and Antigen-Driven Predetermination of Antibody Repertoires throughout B Cell Development

A continuum of CD4+ T cell “help” defines Memory B cell fate

Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations